title: Effects of butylated hydroxyanisole and butylated hydroxytoluene on DNA adduct formation and arylamine N-acetyltransferase activity in human bladder tumour cells.
abstract: In this study, butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) were used to determine the inhibition of arylamine N-acetyltransferase (NAT) activity and DNA adduct formation in human bladder tumour cell line T-24. The activity of NAT was measured by high-performance liquid chromatography, assaying for the amounts of N-acetyl-2-aminofluorene and N-acetyl-p-aminobenzoic acid and remaining 2-aminofluorene and p-aminobenzoic acid. Human bladder tumour cell line T-24 cytosols and intact cells were used for examining NAT activity and carcinogen-DNA adduct formation. The results demonstrated that NAT activity and 2-aminofluorene-DNA adduct formation in human bladder tumour cells were inhibited and decreased by BHA and BHT in a dose-dependent manner. The effects of BHA and BHT on the values of the apparent K(m) and V(max) also were determined in both systems examined. The results indicated that BHA and BHT decreased the apparent values of K(m) and V(max) from human bladder tumour cells in both cytosol and intact cells.
authors.affiliation: Department of Urology, China Medical College Hospital, 2 Yuh-Der Rd, Taichung 400, Taiwan, Republic of China.
authors.forename: Hsueh-Fu
authors.initials: HF
authors.lastname: Lu
authors.forename: Hsi-Chin
authors.initials: HC
authors.lastname: Wu
authors.forename: Te-Chun
authors.initials: TC
authors.lastname: Hsia
authors.forename: Wen-Chi
authors.initials: WC
authors.lastname: Chen
authors.forename: Chi-Fu
authors.initials: CF
authors.lastname: Hung
authors.forename: Jing-Gung
authors.initials: JG
authors.lastname: Chung
mesh_terms: D015073:2-Acetylaminofluorene / Q000031:analogs & derivatives* / Q000378:metabolism; D010129:4-Aminobenzoic Acid / Q000378:metabolism; D000975:Antioxidants / Q000008:administration & dosage*; D001191:Arylamine N-Acetyltransferase / Q000187:drug effects* / Q000378:metabolism; D002083:Butylated Hydroxyanisole / Q000008:administration & dosage*; D002084:Butylated Hydroxytoluene / Q000008:administration & dosage*; D002273:Carcinogens / Q000008:administration & dosage*; D018736:DNA Adducts / Q000187:drug effects*; D005449:Fluorenes / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D014407:Tumor Cells, Cultured; D001749:Urinary Bladder Neoplasms / Q000378:metabolism / Q000473:pathology; D062366:para-Aminobenzoates
chemical_list: D000975:Antioxidants; D002273:Carcinogens; D018736:DNA Adducts; D005449:Fluorenes; D062366:para-Aminobenzoates; C023730:Acedoben; D002084:Butylated Hydroxytoluene; D002083:Butylated Hydroxyanisole; C012177:2-aminofluorene; D015073:2-Acetylaminofluorene; D001191:Arylamine N-Acetyltransferase; D010129:4-Aminobenzoic Acid